FDA approves pembrolizumab for adults and children with TMB-H solid tumors HEALTH U.S. ONCOLOGIA PEDIATRIA FDA approves pembrolizumab for adults and children with TMB-H solid tumors Redazione 17 Giugno 2020 On June 16, 2020, the Food and Drug Administration granted accelerated approval to pembrolizumab (KEYTRUDA, Merck &... Per saperne di più Maggiori informazioni su FDA approves pembrolizumab for adults and children with TMB-H solid tumors
